The Centers for Medicare & Medicaid Services (CMS) has added several changes to the Medicare price negotiation process ...

Merck (MRK) is one of the worst-performing stocks in the Dow Jones Industrial Average (DJIA) on Thursday. The US government ...

Shares of Merck Merck & Co. Inc. and Intel Intel Corp. have contributed to the blue-chip gauge's intraday decline, as the Dow Dow Jones Industrial Average was most recently trading 290 points, or 0.7% ...

Merck (MRK) ended the recent trading session at $110.18, demonstrating a -1.7% swing from the preceding day's closing price. This change lagged the S&P 500's 0.17% loss on the day. Meanwhile, the Dow ...

Report on how AI is driving market transformation- The global enzyme-linked immunosorbent assay (elisa) market size is ...

The increasing incidence of respiratory conditions like asthma, COPD, and bronchitis mainly drives the growth of the inhalable drugs market. Additionally, the rising prevalence of diabetes and ...

Hot on the tail of AstraZeneca’s Imfinzi, Bristol Myers Squibb’s PD-1/L1 inhibitor Opdivo has expanded its non-small cell lung cancer (NSCLC) net with an ...

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ...

In this week's edition of Petri Dish, a Boston cancer biotech is on the hunt for a new CFO, a startup has signed a deal ahead ...

Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and repurposing existing drugs to address unmet medical needs. This ...

Presented in partnership with the Perricelli-Gegnas Center for Entrepreneurship & Innovation, O’Leary will appear in the Weis ...

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara ...